The race to create vaccines against the novel coronavirus is entering a critical stretch, with several candidates that were first out of the gate beginning to release late-stage trial data and possibly seeking early regulatory approval. Multiple “winners” are likely to make it to market, and success will depend on a number of factors reflected in this tracker by Reuters.
Topics of Interest: Health
Type: Reuters Best
Regions: AfricaAsiaEmerging MarketsEuropeMiddle EastNorth AmericaSouth America
Win Types: Overall Coverage
Media Types: Graphics
Customer Impact: Major Global Story